Cells from the metastatic tumor 147L lacked RIPK3 expression, yet SM-164 sensitized these cells to TNFα as efficiently as cells from the RIPK3-expressing tumors 493L and 1029LV. This evidence concerns the gene RIPK3 and metastatic neoplasm.